ginsenoside rh2 has been researched along with Urinary Incontinence, Stress in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HY; Chen, WC; Chen, YH; Hsieh, WT; Lin, YN | 1 |
| Al-Shaiji, TF; Malallah, MA | 1 |
1 review(s) available for ginsenoside rh2 and Urinary Incontinence, Stress
| Article | Year |
|---|---|
Pharmacological treatment of pure stress urinary incontinence: a narrative review.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Duloxetine Hydrochloride; Estrogen Replacement Therapy; Ginsenosides; Humans; Off-Label Use; Serotonin and Noradrenaline Reuptake Inhibitors; Urinary Incontinence, Stress | 2015 |
1 other study(ies) available for ginsenoside rh2 and Urinary Incontinence, Stress
| Article | Year |
|---|---|
Treatment of stress urinary incontinence by ginsenoside Rh2.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Ginsenosides; In Vitro Techniques; Mice, Inbred C57BL; Molecular Targeted Therapy; Muscle Contraction; Myosins; Nitric Oxide; Nitric Oxide Synthase Type II; Panax; Phytotherapy; Receptors, Adrenergic, alpha-1; Superoxide Dismutase; Survival of Motor Neuron 1 Protein; Swine; Urethra; Urinary Incontinence, Stress | 2014 |